American Airlines (NASDAQ: AAL) has begun a multi-year financial commitment of USD1.0 million to the Answer ALS research project through the Answer ALS Foundation to raise awareness of ALS, the company said.
The research project will build the most comprehensive clinical, genetic, molecular and biochemical assessment of ALS, commonly referred to as Lou Gehrig´s disease.
Through this partnership, American Airlines employees and their families will be able to participate in the Answer ALS research project. They will have the opportunity to meet with the top ALS experts at one of the six designated program locations, providing them access to the top researchers and clinicians in the ALS community.
American is also partnering with the Answer ALS Foundation to assist employees and their dependents with navigation of the disease, expert clinic referrals, resources for Medicare benefit information, new assistive technologies such as voice banking and more.
Warlick is launching a fundraising effort — “Warlick´s Warriors” — to help support the Answer ALS research efforts. Donations made through Warlick´s Warriors will be matched by American Airlines up to USD250,000. One hundred percent of the funds donated will go directly to the Answer ALS research project.
The Answer ALS project involves 1,000 patients and nearly two dozen research entities at leading institutions. There are six clinical sites for the project: Johns Hopkins University, Massachusetts General Hospital, Washington University, Ohio State University, Emory University and Cedars-Sinai Medical Center.
American Airlines and American Eagle offer an average of nearly 6,700 flights per day to nearly 350 destinations in more than 50 countries. The airlines operates service to 1,000 destinations with 14,250 daily flights to 150 countries.